
Investors
Committed to providing timely, high-quality information.
Welcome
Control Bionics Investor Relations
Our most recent key ASX announcements together with our corporate governance policies can be found here.
If you have any further questions regarding investing in Control Bionics Limited, please contact Brett Crowley, Company Secretary, at brettcrowley@controlbionics.com or at +61 411 713 555.
Latest News
- Control Bionics’ (ASX:CBL) COSMOS Connect: A promise for life-enjoying experiencesControl Bionics was featured in an article by Kalkine Media discussing the company’s latest launch, COSMOS Connect.
- Featured Article: Control Bionics Limited commences full-scale operations in JapanControl Bionics was featured in an article on JETRO’s site announcing the expansion of our AAC technology into Japan. Read the full article.
- Control Bionics Integrates State-of-the-Art Eye Gaze Camera into Product OfferingsControl Bionics is excited to announce the integration of the Hiru eye gaze camera into our AAC solutions. With the addition of the Hiru, Control Bionics will be able to offer the latest in eye gaze technology.
- Control Bionics (ASX:CBL) delivers solid March quarter with 90% jump in US salesControl Bionics (ASX:CBL) delivers solid March quarter with 90% jump in US sales.
- Introducing the Cosmos Connect from Control BionicsWe’re constantly working towards our mission of making life-changing connections which brought us to our latest product offering, the Cosmos Connect.
Leadership
Board of Directors

Founder and Director of Innovation
Peter Ford
For some people, Peter’s face may be familiar from his time as a CNN news anchor. But Peter’s real passion has always been bionics and robotics. In particular, he was inspired by the potential to help free one of the world’s great minds, Stephen Hawking.
In 1999, Peter identified that the patients’ damaged muscles still emitted small electrical signals that could be used to reliably control basic computer functions. And with that, Control Bionics was born.

Chairman
Roger Hawke
Roger has over 30 years of experience in the telecommunications and technology space, having recently retired after 8 years as CEO & Managing Director of Crown Castle Australia/Axicom, and brings a high level of experience particularly in Technology, Operations, Sales and Management.
Roger holds BEng (SAIT), MES (Sydney) and MBA (Macquarie) degrees and is a Member of the Australian Institute of Company Directors.
Roger joined the Board of Control Bionics in October 2018.

CEO
Rob Wong
Rob Wong is the Chief Executive Officer for Control Bionics. He holds a Bachelor of Business and an MBA from Melbourne University. Rob has over 25 years of experience with multinational businesses in senior management, marketing, and operational roles. He is also an entrepreneur and angel investor having been involved with several successful tech start-up businesses. He formerly held the position of CEO at AIMIA Digital Industry Association of Australia.
Rob joined Control Bionics in early 2017 and he has led the way in developing their latest product, the NeuroNode Trilogy. Rob has spent much of his time with Control Bionics presenting to industry leaders, forming research and development relations, and working hands-on with clients across the world.

Board Member
Lindsay Phillips
As a highly-experienced private equity fund Managing Director and Chairman, Lindsay is a key member of the Control Bionics’ leadership team. Lindsay first invested in Control Bionics in 2005.
Lindsay was Managing Director of Lazard Australia Private Equity from 2007 to 2012. Since 2012 Lindsay has been Chairman of Phoenix Development Fund and Nightingale Partners. He holds a Bachelor of Commerce from the University of Western Australia and is a member of the Institute of Chartered Accountants of Australia.

Board Member
Damian Lismore
Damian has held a number of Directorships and has extensive commercial, international and listed company experience (both ASX and NASDAQ), covering many industries including healthcare and technology. In his executive career, he held CEO, CFO and Company Secretarial roles and continues to act as an advisor to CEOs, boards and business owners. Damian joined the Control Bionics board in September 2020 and is a Graduate Member of Australian Institute of Company Directors, Member of Chartered Accountants Australia and New Zealand, Fellow of Chartered Accountants in Ireland and holds a BA (Honours) Accountancy. Damian is currently CFO of Scout Bio Inc, a Frazier Healthcare Partners backed company, and a Non-Executive Director of ASX listed LBT Innovations Limited (ASX:LBT).

Company Secretary
Brett Crowley
Brett is a practicing solicitor and a former Partner of Ernst & Young in Hong Kong and Australia, and of KPMG in Hong Kong. He is a former Senior Legal Member of the NSW Guardianship Tribunal and the NSW Civil and Administrative Tribunal.
Brett has extensive ASX-listed company experience. He is currently chairman of Jatcorp Limited (ASX:JAT) and company secretary of three other ASX-listed companies.